Medical Subject Headings / 医学主题词表

Last uploaded: September 7, 2023
Preferred Name

Canagliflozin

Synonyms

Invokana

Definitions

A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

ID

http://purl.bioontology.org/ontology/MESH/D000068896

altLabel

Invokana

Canagliflozin Hemihydrate

Canagliflozin, Anhydrous

1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973

AQL

AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR

cui

C2983989

C2974540

C4042822

C3556179

DC

1

definition

A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

DX

20160101

HN

2016 (2014)

Inverse of AQ

http://purl.bioontology.org/ontology/MESH/Q000032

http://purl.bioontology.org/ontology/MESH/Q000138

http://purl.bioontology.org/ontology/MESH/Q000737

http://purl.bioontology.org/ontology/MESH/Q000493

http://purl.bioontology.org/ontology/MESH/Q000145

http://purl.bioontology.org/ontology/MESH/Q000506

http://purl.bioontology.org/ontology/MESH/Q000819

http://purl.bioontology.org/ontology/MESH/Q000037

http://purl.bioontology.org/ontology/MESH/Q000134

http://purl.bioontology.org/ontology/MESH/Q000592

http://purl.bioontology.org/ontology/MESH/Q000528

http://purl.bioontology.org/ontology/MESH/Q000008

http://purl.bioontology.org/ontology/MESH/Q000031

http://purl.bioontology.org/ontology/MESH/Q000276

http://purl.bioontology.org/ontology/MESH/Q000191

http://purl.bioontology.org/ontology/MESH/Q000633

http://purl.bioontology.org/ontology/MESH/Q000652

http://purl.bioontology.org/ontology/MESH/Q000009

http://purl.bioontology.org/ontology/MESH/Q000302

http://purl.bioontology.org/ontology/MESH/Q000494

http://purl.bioontology.org/ontology/MESH/Q000266

http://purl.bioontology.org/ontology/MESH/Q000600

http://purl.bioontology.org/ontology/MESH/Q000378

http://purl.bioontology.org/ontology/MESH/Q000097

http://purl.bioontology.org/ontology/MESH/Q000627

Inverse of RB

6S49DGR869

0SAC974Z85

0

isa

http://purl.bioontology.org/ontology/MESH/D000077203

LT

TRD

Machine permutation

2016; CANAGLIFLOZIN was indexed under GLUCOSIDES and THIOPHENES 2014-2015

Mapped from

http://purl.bioontology.org/ontology/MESH/C000711712

MDA

20150701

MMR

20180228

MN

D09.408.348.113

D02.886.778.075

D03.383.903.075

notation

D000068896

PA

D000077203

prefLabel

Canagliflozin

RR

6S49DGR869

928672-86-0 (Hemihydrate)

TERMUI

T000877693

T000901404

T000864357

T000877692

T000877695

TH

NLM (2017)

FDA SRS (2013)

USAN (19XX)

NLM (2016)

NLM (2010)

NLM (2014)

tui

T109

T121

subClassOf

http://purl.bioontology.org/ontology/MESH/D013876

http://purl.bioontology.org/ontology/MESH/D005960

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C91018 National Cancer Institute Thesaurus / 美国国家癌症研究所词典 LOOM
http://purl.obolibrary.org/obo/CHEBI_73274 Chemical Entities of Biological Interest Ontology / 生物相关的化学实体本体 LOOM
http://purl.obolibrary.org/obo/CHEBI_73274 The Drug Ontology / 药物本体 LOOM
http://purl.bioontology.org/ontology/ATC/A10BK02 Anatomical Therapeutic Chemical Classification / 解剖学治疗学及化学分类系统 CUI
http://purl.bioontology.org/ontology/ATC/A10BK02 Anatomical Therapeutic Chemical Classification / 解剖学治疗学及化学分类系统 LOOM